← Back to headlines
FDA's Shifting Stance on Rare Disease Drugs
The FDA is facing scrutiny for its inconsistent actions regarding rare disease drugs, despite public statements supporting their development.
28 Feb, 20:14 — 28 Feb, 20:14
ℹOnly 1 source covers this story
